Last updated on October 2018

Efficacy and Safety of INCB054828 in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)

Brief description of study

The purpose of this study is evaluate the efficacy of INCB054828 in subjects with advanced/metastatic or surgically unresectable cholangiocarcinoma with FGFR2 translocation who have failed at least 1 previous treatment.

Clinical Study Identifier: NCT02924376

Contact Investigators or Research Sites near you

Start Over

Incyte Corporation Call Center

San Giovanni Rotondo, Italy
  Connect »